Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

581 related articles for article (PubMed ID: 28159516)

  • 1. Tumor-targeted pH/redox dual-sensitive unimolecular nanoparticles for efficient siRNA delivery.
    Chen G; Wang Y; Xie R; Gong S
    J Control Release; 2017 Aug; 259():105-114. PubMed ID: 28159516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aminoflavone-loaded EGFR-targeted unimolecular micelle nanoparticles exhibit anti-cancer effects in triple negative breast cancer.
    Brinkman AM; Chen G; Wang Y; Hedman CJ; Sherer NM; Havighurst TC; Gong S; Xu W
    Biomaterials; 2016 Sep; 101():20-31. PubMed ID: 27267625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. gH625 Cell-Penetrating Peptide Promotes the Endosomal Escape of Nanovectorized siRNA in a Triple-Negative Breast Cancer Cell Line.
    Ben Djemaa S; Hervé-Aubert K; Lajoie L; Falanga A; Galdiero S; Nedellec S; Soucé M; Munnier E; Chourpa I; David S; Allard-Vannier E
    Biomacromolecules; 2019 Aug; 20(8):3076-3086. PubMed ID: 31305991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimuli-responsive release and efficient siRNA delivery in non-small cell lung cancer by a poly(l-histidine)-based multifunctional nanoplatform.
    Shi M; Zhang J; Huang Z; Chen Y; Pan S; Hu H; Qiao M; Chen D; Zhao X
    J Mater Chem B; 2020 Feb; 8(8):1616-1628. PubMed ID: 32010914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual-responsive polyplexes with enhanced disassembly and endosomal escape for efficient delivery of siRNA.
    Zhu J; Qiao M; Wang Q; Ye Y; Ba S; Ma J; Hu H; Zhao X; Chen D
    Biomaterials; 2018 Apr; 162():47-59. PubMed ID: 29432988
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Wan X; Sun R; Bao Y; Zhang C; Wu Y; Gong Y
    Mol Pharm; 2021 Nov; 18(11):3990-3998. PubMed ID: 34591491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pH-Triggered Triblock Nanocarrier Enabled Highly Efficient siRNA Delivery for Cancer Therapy.
    Du L; Zhou J; Meng L; Wang X; Wang C; Huang Y; Zheng S; Deng L; Cao H; Liang Z; Dong A; Cheng Q
    Theranostics; 2017; 7(14):3432-3445. PubMed ID: 28912886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted nanomedicine with anti-EGFR scFv for siRNA delivery into triple negative breast cancer cells.
    Nguyen PV; Hervé-Aubert K; David S; Lautram N; Passirani C; Chourpa I; Aubrey N; Allard-Vannier E
    Eur J Pharm Biopharm; 2020 Dec; 157():74-84. PubMed ID: 33059006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A peptide-targeted delivery system with pH-sensitive amphiphilic cell membrane disruption for efficient receptor-mediated siRNA delivery.
    Wang XL; Xu R; Lu ZR
    J Control Release; 2009 Mar; 134(3):207-13. PubMed ID: 19135104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repurposing cationic amphiphilic drugs as adjuvants to induce lysosomal siRNA escape in nanogel transfected cells.
    Joris F; De Backer L; Van de Vyver T; Bastiancich C; De Smedt SC; Raemdonck K
    J Control Release; 2018 Jan; 269():266-276. PubMed ID: 29146245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic delivery of therapeutic small interfering RNA using a pH-triggered amphiphilic poly-L-lysine nanocarrier to suppress prostate cancer growth in mice.
    Guo J; Cheng WP; Gu J; Ding C; Qu X; Yang Z; O'Driscoll C
    Eur J Pharm Sci; 2012 Apr; 45(5):521-32. PubMed ID: 22186295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. pH-Sensitive Shell-Core Platform Block DNA Repair Pathway To Amplify Irreversible DNA Damage of Triple Negative Breast Cancer.
    Dong Y; Liao H; Fu H; Yu J; Guo Q; Wang Q; Duan Y
    ACS Appl Mater Interfaces; 2019 Oct; 11(42):38417-38428. PubMed ID: 31556584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Core-shell type lipid/rPAA-Chol polymer hybrid nanoparticles for in vivo siRNA delivery.
    Gao LY; Liu XY; Chen CJ; Wang JC; Feng Q; Yu MZ; Ma XF; Pei XW; Niu YJ; Qiu C; Pang WH; Zhang Q
    Biomaterials; 2014 Feb; 35(6):2066-78. PubMed ID: 24315577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual-targeting and pH/redox-responsive multi-layered nanocomplexes for smart co-delivery of doxorubicin and siRNA.
    Han L; Tang C; Yin C
    Biomaterials; 2015 Aug; 60():42-52. PubMed ID: 25982552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced delivery of siRNA to triple negative breast cancer cells in vitro and in vivo through functionalizing lipid-coated calcium phosphate nanoparticles with dual target ligands.
    Tang J; Howard CB; Mahler SM; Thurecht KJ; Huang L; Xu ZP
    Nanoscale; 2018 Mar; 10(9):4258-4266. PubMed ID: 29436549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-delivery of EGFR and BRD4 siRNA by cell-penetrating peptides-modified redox-responsive complex in triple negative breast cancer cells.
    Zhang C; Yuan W; Wu Y; Wan X; Gong Y
    Life Sci; 2021 Feb; 266():118886. PubMed ID: 33310044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic siRNA delivery to tumors by cell-penetrating α-helical polypeptide-based metastable nanoparticles.
    Liu Y; Song Z; Zheng N; Nagasaka K; Yin L; Cheng J
    Nanoscale; 2018 Aug; 10(32):15339-15349. PubMed ID: 30070662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-assembly cationic nanoparticles based on cholesterol-grafted bioreducible poly(amidoamine) for siRNA delivery.
    Chen CJ; Wang JC; Zhao EY; Gao LY; Feng Q; Liu XY; Zhao ZX; Ma XF; Hou WJ; Zhang LR; Lu WL; Zhang Q
    Biomaterials; 2013 Jul; 34(21):5303-16. PubMed ID: 23570718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Folate-decorated PEGylated triblock copolymer as a pH/reduction dual-responsive nanovehicle for targeted intracellular co-delivery of doxorubicin and Bcl-2 siRNA.
    Suo A; Qian J; Xu M; Xu W; Zhang Y; Yao Y
    Mater Sci Eng C Mater Biol Appl; 2017 Jul; 76():659-672. PubMed ID: 28482576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. pH/Redox Dual-Responsive Polyplex with Effective Endosomal Escape for Codelivery of siRNA and Doxorubicin against Drug-Resistant Cancer Cells.
    Gao Y; Jia L; Wang Q; Hu H; Zhao X; Chen D; Qiao M
    ACS Appl Mater Interfaces; 2019 May; 11(18):16296-16310. PubMed ID: 30997984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.